Physiological Dead Space Assessment

Fundamental Equations

The Bohr equation defines physiological dead space as the ratio of dead‑space volume to tidal volume (VD/VT) equal to the difference between arterial CO₂ tension (PaCO₂) and mixed‑expired CO₂ tension (PECO₂) divided by PaCO₂, yielding a dimensionless fraction that represents the proportion of each breath that does not participate in gas exchange. 1, 2, 3
In mechanically ventilated patients, the equation is modified to include the dead space contributed by the ventilator circuit (VDvalve): VD/VT = [(PaCO₂ – PECO₂)/PaCO₂] + (VDvalve/VT). 1, 2, 3
The ventilator‑circuit dead space (VDvalve) comprises the volume of the mouthpiece, valve, and breathing circuit that adds to the total physiological dead space. 1, 2

Accurate calculation of VD/VT requires two measurements: arterial PaCO₂ obtained from an arterial blood gas sample, and mixed‑expired CO₂ tension (PECO₂) obtained by collecting expired gas in a large, gas‑impermeable bag or by sampling from a mixing chamber in modern exercise systems. 1, 2
For breath‑by‑breath analysis, PECO₂ can be derived from the ratio of carbon dioxide production to minute ventilation (VCO₂/VE), provided both gas volumes are expressed under standard temperature, pressure, dry (STPD) conditions. 1

The VD/VT ratio quantifies the fraction of each breath that is “wasted” ventilating anatomic dead space (conducting airways) and alveolar dead space (ventilated but poorly perfused alveoli). 4, 5, 6, 1, 2, 3
An elevated VD/VT indicates inefficient ventilation due to ventilation‑perfusion mismatch or right‑to‑left shunt, necessitating increased minute ventilation to maintain arterial PaCO₂. 1, 2, 3

End‑tidal CO₂ tension (PETCO₂) must not be used as a surrogate for arterial PaCO₂, especially in individuals with lung disease, because PETCO₂ can exceed PaCO₂ during exercise in healthy subjects and there are no reliable non‑invasive methods to estimate PaCO₂ accurately in diseased lungs. 1, 2, 3
Breathing pattern markedly influences VD/VT measurements; rapid, shallow breathing can raise VD/VT values even in the absence of true ventilation‑perfusion abnormalities. 1, 2, 3

The deadspace fraction (VD/VT) is calculated using the modified Bohr equation: VD/VT = (PaCO2 - PECO2)/PaCO2, where PaCO2 is arterial CO2 and PECO2 is mixed expired CO2, as recommended by the European Respiratory Society and the American Thoracic Society 7, 8

Arterial PCO2 (PaCO2) is obtained from arterial blood gas analysis, a crucial measurement for calculating deadspace fraction, according to the American Journal of Respiratory and Critical Care Medicine 8
Mixed expired PCO2 (PECO2) is measured by collecting expired gas in a mixing chamber or calculated from VCO2/VE ratio in breath-by-breath systems, as stated by the American Journal of Respiratory and Critical Care Medicine 8

The modified equation for mechanically ventilated patients is VD/VT = [(PaCO2 - PECO2)/PaCO2] + (VDvalve/VT), where VDvalve is the dead space of the ventilator circuit, valve, and connections, and VT is tidal volume, as recommended by the American Thoracic Society 8

Normal deadspace fraction at rest is approximately 0.34, and during exercise, it decreases to ≤0.10 in healthy individuals, according to Praxis Medical Insights 9
In mechanically ventilated patients with ARDS, a deadspace fraction >0.6 is clearly abnormal and associated with significantly higher mortality, as reported by Praxis Medical Insights 9

A VE/VCO2 slope >38 indicates abnormal ventilation efficiency, suspecting elevated deadspace, as indicated by Praxis Medical Insights 9
PaCO2 failing to decrease despite high minute ventilation and presence of metabolic acidosis may also indicate elevated deadspace, according to Praxis Medical Insights 9

Total apparatus dead space should not exceed 2.0 mL/kg body weight, as recommended by the American Journal of Respiratory and Critical Care Medicine 10, 11
Gas volumes must be expressed in STPD (standard temperature, pressure, dry) conditions for VCO2/VE calculations, as stated by the American Journal of Respiratory and Critical Care Medicine 8